Innovation Pharmaceuticals Inc (IPIX)

[frrol]

It's GAAP accounting (specifically around payables) and the CF statement. The only ambiguity is how much of the remaining approx $1.3MM of third-party (ie, non-related) AP is due the P CRO vs our trade payables (eg, utilities, our office supplies bill, other CROs, etc). So $1.3MM would be the upper limit of what could be payable to the P CRO. (Do you see I get to the $1.3MM limit?)

I will caveat that if the P CRO had not yet completed their work as of Sep 30 then some of the remaining "contractual obligations" of $3MM would belong to them and we would ultimately owe that to them too. But according to the company they are done with their work and are just waiting to get paid.